TB-500 (Thymosin Beta-4) 10mg (10 Vials)

Overview

TB-500 is a laboratory research material used to examine peptide behavior, cytoskeletal interactions, and cellular-response pathways in controlled experimental models. References to biological effects are provided for scientific context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit. This product is not offered for human or veterinary use.

TB-500 (Thymosin Beta) : Structure

Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S

Molar Mass: 4963.4408 Da

CAS Number: 77591-33-4

PubChem CID: 16132341

Synonyms: Thymosin Beta-4

TB-500 in Research Settings

In laboratory research, TB-500 is examined for its interaction with actin-related pathways and downstream cellular responses. Studies may focus on membrane behavior, cell movement, and experimental model development in controlled research environments. These references are included solely for scientific context and should not be interpreted as claims of medical benefit.

Biological Mechanisms Explored in TB-500 Research

TB-500 is used in laboratory studies involving actin-binding behavior, cytoskeletal organization, and cellular-response analysis. Any references to tissue remodeling or oxidative-stress pathways are provided only for research context and do not imply therapeutic or clinical use.

Key Research Areas Involving TB-500

TB-500 is used in experimental research investigating:

• actin regulation

• cellular migration

• tissue-structure analysis

• angiogenesis-related signaling

• oxidative-stress pathway research

• assay development

All references to biological pathways are provided for research context only and do not imply human or veterinary applications.

TB-500 (10 mg) Peptide Specifications

• High-purity synthetic peptide

• Lyophilized powder for enhanced stability

• 10 mg format suitable for diverse research protocols

• Manufactured in controlled, sterile laboratory conditions

• Designed for experimental reproducibility and consistency

Each vial is produced to support accurate reconstitution and precise measurement within research applications.

Why Choose Licensed Peptides for TB-500 (Thymosin Beta-4) 10mg?

At Licensed Peptides, we’re committed to offering premium-quality TB-500 (Thymosin Beta-4) 10mg at the most competitive prices, without ever sacrificing reliability or service. Proudly operating in the United States, we ensure exceptional value, fast fulfillment, and secure, professional packaging designed to protect the integrity of every vial from our facility to your doorstep.

Ordering TB-500 from us is effortless. Our streamlined checkout process is fast, encrypted, and accepts all major credit and debit cards for a smooth and convenient experience. Once your payment is confirmed, your order is packed with care and shipped promptly, ensuring you receive your research materials quickly, safely, and exactly when you need them.

Research-Only Positioning and Compliance

TB-500 is not approved for human or animal consumption. All descriptions, mechanisms, and applications discussed are derived from preclinical, in vitro, or experimental research models only. No statements herein should be interpreted as medical claims, therapeutic recommendations, or performance outcomes.

Frequently Asked Questions (FAQs) – TB-500 (Thymosin Beta-4) 10 mg

What is TB-500?

TB-500 is a synthetic peptide modeled after the active region of Thymosin Beta-4 and used to study actin-related signaling in experimental systems.

What is TB-500 studied for in research settings?

Researchers examine TB-500 for its role in actin regulation, cellular migration, angiogenic signaling, and structural pathway studies.

Is TB-500 the same as full-length Thymosin Beta-4?

No. TB-500 represents a simplified research fragment modeled after the active region of Thymosin Beta-4.

How does TB-500 function at the cellular level?

TB-500 interacts with monomeric actin (G-actin), influencing cytoskeletal organization and cell movement in experimental models.

Why TB-500 is considered a systemic research peptide?

Because it is studied across multiple tissue systems in experimental models rather than a single localized pathway.

Can TB-500 be combined with other peptides in research?

Yes. Researchers sometimes explore TB-500 alongside other peptides to study complementary or comparative mechanisms within controlled experimental designs.

What does existing literature suggest about TB-500 safety in research environments?

Published studies are used to inform laboratory research context only and do not indicate approval for human or veterinary use.

How TB-500 is typically stored for research purposes?

Unreconstituted TB-500 is usually stored under refrigeration to preserve stability. After reconstitution, continued cold storage is often used to maintain peptide integrity.

How long do researchers observe biological activity in studies?

Observed molecular or cellular changes vary depending on the experimental design and model conditions.

Does TB-500 influence inflammation pathways in studies?

Yes. Researchers study its interaction with inflammatory cytokines and regulatory pathways in controlled laboratory environments.

How does TB-500 differ mechanistically from BPC-157?

TB-500 is primarily studied for actin dynamics and cellular migration, while BPC-157 is more commonly studied for gastrointestinal and cytoprotective pathways.

Is TB-500 associated with hormonal pathways?

No. Research indicates TB-500 is non-hormonal and is studied separately from endocrine signaling systems.

Can TB-500 be used outside of research laboratories?

No. TB-500 is strictly limited to laboratory and preclinical research environments and is not intended for diagnostic, therapeutic, or consumption purposes.

TB-500 (Thymosin Beta) : Research

TB-500 is used in laboratory studies to examine actin-binding behavior, cell-migration pathways, and tissue-structure responses under controlled experimental conditions. Any references to research models are provided only for context and do not imply therapeutic, diagnostic, or clinical use.

Referenced Citations

Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999 Sep;113(3):364-8. doi: 10.1046/j.1523-1747.1999.00708.x. PMID: 10469335.

Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. 2003 Jan-Feb;11(1):19-24. doi: 10.1046/j.1524-475x.2003.11105.x. PMID: 12581423.

Peng H, Xu J, Yang XP, Dai X, Peterson EL, Carretero OA, Rhaleb NE. Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction. Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H741-51. doi: 10.1152/ajpheart.00129.2014. Epub 2014 Jul 11. PMID: 25015963; PMCID: PMC4187393.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products available on this website are intended solely for in-vitro research purposes (Latin: “in glass”), meaning they are used in experiments conducted outside a living organism. These products are not medicines or drugs, have not been evaluated or approved by the U.S. Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Any administration to humans or animals, whether by ingestion, injection, or other means, is strictly prohibited by law.